Rhenman & Partners Asset Management Ab 10x Genomics, Inc. Transaction History

Rhenman & Partners Asset Management Ab

  • $1.2 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
SELL
$40.86 - $62.98 $2.78 Million - $4.28 Million
-68,000 Reduced 50.0%
68,000 $2.81 Million
Q2 2023

Aug 11, 2023
SELL
$50.96 - $58.72 $713,440 - $822,080
-14,000 Reduced 9.33%
136,000 $7.59 Million
Q1 2023

May 11, 2023
BUY
$35.33 - $55.79 $2.65 Million - $4.18 Million
75,000 Added 100.0%
150,000 $8.37 Million
Q3 2022

Nov 14, 2022
BUY
$28.48 - $52.59 $2.14 Million - $3.94 Million
75,000 New
75,000 $2.04 Million

Others Institutions Holding TXG

# of Institutions
291
Shares Held
94.7M
Call Options Held
263K
Put Options Held
85.1K
View Full List

About 10x Genomics, Inc.

TXG Quotes by TradingView
  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.5B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Rhenman & Partners Asset Management Ab Portfolio

Follow Rhenman & Partners Asset Management Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

News

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email